These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 8190025)

  • 21. Scyllo-inositol in normal aging human brain: 1H magnetic resonance spectroscopy study at 4 Tesla.
    Kaiser LG; Schuff N; Cashdollar N; Weiner MW
    NMR Biomed; 2005 Feb; 18(1):51-5. PubMed ID: 15468140
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of lithium and amphetamine on inositol metabolism in the human brain as measured by 1H and 31P MRS.
    Silverstone PH; Rotzinger S; Pukhovsky A; Hanstock CC
    Biol Psychiatry; 1999 Dec; 46(12):1634-41. PubMed ID: 10624544
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sodium-dependent uptake of [3H]scyllo-inositol by Tetrahymena: incorporation into phosphatidylinositol, phosphatidylinositol-linked glycans, and polyphosphoinositols.
    Ryals PE; Kersting MC
    Arch Biochem Biophys; 1999 Jun; 366(2):261-6. PubMed ID: 10356291
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low visual cortex GABA levels in hepatic encephalopathy: links to blood ammonia, critical flicker frequency, and brain osmolytes.
    Oeltzschner G; Butz M; Baumgarten TJ; Hoogenboom N; Wittsack HJ; Schnitzler A
    Metab Brain Dis; 2015 Dec; 30(6):1429-38. PubMed ID: 26359122
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myo-inositol transport through the blood-brain barrier.
    Spector R
    Neurochem Res; 1988 Aug; 13(8):785-7. PubMed ID: 3173626
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of increased scyllo-inositol in brain with magnetic resonance spectroscopy after dietary supplementation in Alzheimer's disease mouse models.
    Choi JK; Carreras I; Dedeoglu A; Jenkins BG
    Neuropharmacology; 2010; 59(4-5):353-7. PubMed ID: 20399219
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis of all possible regioisomers of scyllo-inositol phosphate.
    Chung SK; Kwon YU; Chang YT; Sohn KH; Shin JH; Park KH; Hong BJ; Chung IH
    Bioorg Med Chem; 1999 Nov; 7(11):2577-89. PubMed ID: 10632068
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myo-Inositol transport in Klebsiella aerogenes. scyllo-Inositol, a non-metabolizable substrate for the study of the myo-inositol transport system.
    Deshusses J; Reber J
    Eur J Biochem; 1977 Jan; 72(1):87-91. PubMed ID: 319004
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Magnetic resonance imaging and localized in vivo proton spectroscopy in patients with fulminant hepatic failure.
    Gupta RK; Saraswat VA; Poptani H; Dhiman RK; Kohli A; Gujral RB; Naik SR
    Am J Gastroenterol; 1993 May; 88(5):670-4. PubMed ID: 8480729
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Brain edema dynamics in patients with overt hepatic encephalopathy A magnetic resonance imaging study.
    Poveda MJ; Bernabeu A; Concepción L; Roa E; de Madaria E; Zapater P; Pérez-Mateo M; Jover R
    Neuroimage; 2010 Aug; 52(2):481-7. PubMed ID: 20451628
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biosynthesis and production of quercitols and their application in the production of pharmaceuticals: current status and prospects.
    Itoh N
    Appl Microbiol Biotechnol; 2018 Jun; 102(11):4641-4651. PubMed ID: 29663050
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolic disorders of the brain in chronic hepatic encephalopathy detected with H-1 MR spectroscopy.
    Kreis R; Ross BD; Farrow NA; Ackerman Z
    Radiology; 1992 Jan; 182(1):19-27. PubMed ID: 1345760
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Subclinical hepatic encephalopathy: proton MR spectroscopic abnormalities.
    Ross BD; Jacobson S; Villamil F; Korula J; Kreis R; Ernst T; Shonk T; Moats RA
    Radiology; 1994 Nov; 193(2):457-63. PubMed ID: 7972763
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Brain MR Spectroscopy Markers of Encephalopathy Due to Nonalcoholic Steatohepatitis.
    Tran TT; Wei K; Cole S; Mena E; Csete M; King KS
    J Neuroimaging; 2020 Sep; 30(5):697-703. PubMed ID: 32705733
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phosphoinositide metabolism in the developing conceptus. Effects of hyperglycemia and scyllo-inositol in rat embryo culture.
    Strieleman PJ; Connors MA; Metzger BE
    Diabetes; 1992 Aug; 41(8):989-97. PubMed ID: 1321063
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MR and 1H MR spectroscopy of the brain in patients with liver cirrhosis and early stages of hepatic encephalopathy.
    Tarasów E; Panasiuk A; Siergiejczyk L; Orzechowska-Bobkiewicz A; Lewszuk A; Walecki J; Prokopowicz D
    Hepatogastroenterology; 2003; 50(54):2149-53. PubMed ID: 14696484
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distribution of myo-inositol in the cat cochlear nucleus.
    Godfrey DA; Hallcher LM; Laird MH; Matschinsky FM; Sherman WR
    J Neurochem; 1982 Apr; 38(4):939-47. PubMed ID: 7062042
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of a scyllo-inositol-containing sialyloligosaccharide from normal human urine.
    Parkkinen J
    FEBS Lett; 1983 Oct; 163(1):10-3. PubMed ID: 6628680
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Detection of subclinical and overt hepatic encephalopathy and treatment control after L-ornithine-L-aspartate medication by magnetic resonance spectroscopy ((1)H-MRS)].
    Hass HG; Nägele T; Seeger U; Hösl F; Gregor M; Kaiser S
    Z Gastroenterol; 2005 Apr; 43(4):373-8. PubMed ID: 15830303
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Viability assessment of magnetic resonance spectroscopy for the detection of minimal hepatic encephalopathy severity.
    Meng LP; Chen YC; Li YH; Zhu JS; Ye JL
    Eur J Radiol; 2015 Oct; 84(10):2019-23. PubMed ID: 26170124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.